The aetiology of psoriasis: clues provided by benoxaprofen
- 29 July 2006
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 109 (s25) , 126-129
- https://doi.org/10.1111/j.1365-2133.1983.tb06823.x
Abstract
Twenty-four patients with psoriasis completed a double-blind trial of benoxaprofen for their cutaneous lesions. Six out of thirteen on the active drug showed very marked improvement. It is believed that benoxaprofen acts by interfering with the migration of polymorphs into the skin through inhibition of leukotriene B4 synthesis.Keywords
This publication has 3 references indexed in Scilit:
- Benoxaprofen: effect on cutaneous lesions in psoriasis.BMJ, 1982
- Inhibition of rabbit PMN lipoxygenase activity by benoxaprofenJournal of Pharmacy and Pharmacology, 1979
- Separate anti-inflammatory effects of indomethacin, flurbiprofen and benoxaprofenJournal of Pharmacy and Pharmacology, 1977